Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a prevalent hepatic manifestation of metabolic syndrome and is emerging as a leading cause of chronic liver disease globally. Early detection is essential for effective risk stratification and interve...
Open access
Research Article10.9734/ajmah/2025/v23i71277
One of the measurements of obesity is using the Body Mass Index (BMI). The increase in obesity is in line with the increase in type 2 diabetes mellitus. Type 2 DM causes disturbances in lipid metabolism in the body, especially hypertriglyceridemia, decreased HDL, and increased sm...
Open access
Research Article10.9734/ajmah/2023/v21i7843
Dyslipidemia is a risk factor in many health complications, among them is hypertension. Case: This report presents a case of a poorly controlled dyslipidemia that could not be managed by medications. A surprisingly and an unexpected factor interfered; the triglyceride-lowering me...
Open access
Research Article10.9734/ajmah/2020/v18i1030250
Estradiol valerate is used for hormone replacement therapy because it contains the principal oestrogen hormone that is lost during the change of life. Progynova contains estradiol valerate, an ester of the endogenous female estrogen. The main aim of this study was to evaluate the...
Open access
Research Article10.9734/ARRB/2015/14749